机译:珍珠1卢比的临界与中国健康中国志愿者的多态性和药效学
Cent S Univ Xiangya Hosp Dept Clin Pharmacol Changsha 410008 Hunan Peoples R China;
Changzhi Med Coll Dept Cardiol Heping Hosp Changzhi Shanxi Peoples R China;
Cent S Univ Xiangya Hosp Dept Clin Pharmacol Changsha 410008 Hunan Peoples R China;
Cent S Univ Xiangya Hosp Dept Pharm Changsha Hunan Peoples R China;
Cent S Univ Xiangya Hosp Dept Clin Pharmacol Changsha 410008 Hunan Peoples R China;
Cent S Univ Xiangya Hosp Dept Clin Pharmacol Changsha 410008 Hunan Peoples R China;
Cent S Univ Xiangya Hosp Dept Pharm Changsha Hunan Peoples R China;
Cent S Univ Xiangya Hosp Dept Pharm Changsha Hunan Peoples R China;
Cent S Univ Xiangya Hosp Dept Clin Pharmacol Changsha 410008 Hunan Peoples R China;
Cent S Univ Xiangya Hosp Dept Clin Pharmacol Changsha 410008 Hunan Peoples R China;
PEAR1; pharmacokinetics; pharmacodynamics; polymorphisms; ticagrelor;
机译:珍珠1卢比的临界与中国健康中国志愿者的多态性和药效学
机译:CYP2C9和SLCO1B1多态性对那格列奈在中国健康男性志愿者中药代动力学和药效学的影响。
机译:SLCO1B1多态性对瑞格列奈在健康中国志愿者体内的药代动力学和药效学的影响。
机译:在健康男性志愿者中单次皮下注射Teverelix储库制剂后的安全性,耐受性,药效动力学和药代动力学
机译:普罗帕酮药代动力学:GLC-ECD分析;非吸烟和吸烟健康志愿者的苯巴比妥诱导代谢;蛋白质结合;患者的药效学
机译:CYP3A4 * 1G和CYP3A5 * 3基因多态性对替卡格雷的药代动力学和药效学的影响
机译:CYp3a4 * 1G和CYp3a5 * 3基因多态性对替卡格雷在中国健康人群中的药代动力学和药效学的影响